Rick Strassman

https://www.rickstrassman.com/

Rick Strassman is an American clinical associate professor of psychiatry at the University of New Mexico School of Medicine. He has appeared on a variety of media outlets, including The Joe Rogan Experience, and is the author of DMT: The Spirit Molecule, which summarizes his academic research into DMT.

How the Sonoran Desert Toad Became an Obsession of Mainstream Psychedelia

The story began innocently enough in Haiti in the spring of 1982, in the temple of a Vodoun sorcerer as he and a companion gathered...

Ram Dass Was “Only Jewish on My Parents’ Side”

This essay is part of the Lucid News “God on Psychedelics” project, reported and written by veteran religion journalist Don Lattin. To read the complete...

Algernon Pharmaceuticals Announces Dr. Rick Strassman author of “DMT: The Spirit Molecule” to Join CEO Christopher J. Moreau for Keynote Science Address at Wonderland Conference

VANCOUVER, British Columbia, Oct. 14, 2022 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF) a clinical stage...

Algernon Pharmaceuticals Announces Dr. Rick Strassman author of "DMT - GuruFocus

The Keynote Address will review the positive preclinical science and data driving the Company's pioneering Phase 1 clinical study of DMT for the ...

Algernon Pharmaceuticals says DMT research expert Dr Rick Strassman to join CEO for ...

The keynote address will review the positive pre-clinical science and data driving Algernon's pioneering Phase 1 clinical study of DMT for...

Algernon Pharmaceuticals Announces Dr. Rick Strassman author of “DMT - GlobeNewswire

Algernon Pharmaceuticals Announces Dr. Rick Strassman author of “DMT: The Spirit Molecule” to Join CEO Christopher J. Moreau for Keynote Science ...

Algernon Pharmaceuticals Announces Dr. Rick Strassman author of “DMT: The Spirit Molecule” to Join CEO Christopher J. Moreau for Keynote Science Address at Wonderland Conference

Algernon Pharmaceuticals Inc. (CSE: AGN | FRANKFURT: AGW0 | OTCQB: AGNPF) a clinical stage Canadian pharmaceutical development company, is pleased to announce that Dr. Rick...

Decentralizing the Future: Crypto and Psychedelics | Microdose

For more on Algernon and their DMT work, check out Interview with DMT Pioneer Rick Strassman and Key Takeaways from the.

Algernon Pharmaceuticals Receives Approval for Groundbreaking Phase 1 DMT Human Stroke Study

Algernon Pharmaceuticals Inc. (CSE: AGN | FRANKFURT: AGW0 | OTCQB: AGNPF) a clinical stage pharmaceutical development company is pleased to announce that it has received...

Algernon Pharmaceuticals Receives Approval for Phase 1 DMT Study

For more on Algernon and their DMT work, check out Interview with DMT Pioneer Rick Strassman and Key Takeaways from the Algernon Pharmaceuticals PsyCap Presentation. ...

Psychedelic Expert Tells Joe Rogan How DMT Could Have Us All Trapped Inside The Actual Matrix

And Strassman is a collegiate professor, author, and psychedelic/hallucinogenic expert. When it comes to DMT he's one of the field's leading ...

The First Person In The US Who Researched DMT Explains What It Does To The Human Brain | Digg

Dr. Rick Strassman tells Joe Rogan what a DMT trip does to the human brain.

A Deeper Look at DMT Trials & Studies

Preliminary results from Phase 1 DMT clinical trial for depression support the safety and tolerability of the compound. With a world-first Phase 2 trial getting...

Last updated: Apr 16, 2021

Request Deletion